CLINSQUARE: CLINICAL RESEARCH COURSES
Sunday, April 20, 2025
CLINSQUARE: Clinical Rsearch Courses by LIFEPRONOW
Home2020

Yearly Archives: 2020

AbbVie Establish partnership with Frontier Medicines on protein degrader development

admin - 0
December 02, 2020: "AbbVie announced a global strategic collaboration to discover, develop and commercialize a pipeline of innovative small molecule therapeutics against high-interest, difficult-to-drug...

Biostatistics: a panacea for clinical data analysis

admin - 0

FDA approves Xolair® (omalizumab) for adults with nasal polyps

admin - 0
December 01, 2020: "Roche announced that the U.S. Food and Drug Administration (FDA) has approved the company’s supplemental Biologics License Application (sBLA) for Xolair®...

UK authorises Pfizer/BioNTech COVID-19 vaccine

admin - 0
December 02, 2020: "A Department of Health and Social Care spokesperson said: The government has accepted the recommendation from the independent Medicines and Healthcare products Regulatory...

WHO Releases COVID-19 App for Trusted and Timely Updates

admin - 0
 December 01, 2020: The WHO has published a new mobile app to centralize the most trusted updates about COVID-19, and to guide individuals safely...

First PSMA-Targeted PET Imaging Drug for Men with Prostate Cancer approved by FDA

admin - 0
December 01, 2020: The U.S. Food and Drug Administration approved Gallium 68 PSMA-11 (Ga 68 PSMA-11) – the first drug for positron emission tomography...

Eisai and Wren Therapeutics Enter Into Research Collaboration Agreement for Drug Discovery for Synucleinopathies

admin - 0
November 30, 2020: Eisai and Wren Therapeutics announced that the companies have entered into an exclusive research collaboration agreement aiming to advance the discovery...

AstraZeneca agreed to sell rights to Crestor to be divested to Grünenthal in Europe

admin - 0
December 01, 2020: AstraZeneca has agreed to sell the rights to Crestor (rosuvastatin) and associated medicines in over 30 countries in Europe, except the UK and...

AstraZeneca’sForxiga approved in Japan for chronic heart failure

admin - 0
November 30, 2020: AstraZeneca’s Forxiga (dapagliflozin) has been approved in Japan for the treatment of patients with chronic heart failure (HF) who are receiving standard of...

Moderna Announces the EC Approval for Initial 80 Million Doses of mRNA Vaccine Against COVID-19

admin - 0
November 25, 2020: "Moderna, a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients...

BMS Receives EC Approval for Opdivo for Esophageal Squamous Cell Carcinoma

admin - 0
Nov 25, 2020: Bristol Myers Squibb announced that the European Commission (EC) has approved Opdivo (nivolumab) for the treatment of adults with unresectable advanced, recurrent or metastatic esophageal...

Amgen To Transition Development And Commercial Rights to Cytokinetics

admin - 0
Nov. 23, 2020: Amgen announced the Company has provided notice to Cytokinetics of termination of its collaboration and its intention to transition the development and...
1...456...65Page 5 of 65
- Advertisment -

Most Read

EDITOR PICKS

POPULAR POSTS

POPULAR CATEGORY

ABOUT US

LifeProNow provides guidance and high quality contents to help job seekers to get their dream Job. All the contents are written by experienced folks and peer reviewed by experts.

Contact us: [email protected]

FOLLOW US

© LifeProNow | All Rights Reserved